NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 755264 | Null | 0.0352786308082228 | 0.32110298 |
NSC 760016 | (E)-3-(3,5-dimethoxyphenyl)-1-(4-(quinazolin-4-ylamino)phenyl)prop-2-en-1-one | 0.0352786308082228 | 0.29276821 |
NSC 113497 | 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) | 0.0378615809326463 | 0.23932247 |
NSC 114346 | Null | 0.0378615809326463 | 0.46653615 |
NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.0378615809326463 | 0.44410028 |
NSC 23925 | Null | 0.0378615809326463 | 0.2633389 |
NSC 244404 | Null | 0.0378615809326463 | 0.27439077 |
NSC 30915 | Null | 0.0378615809326463 | 0.41705416 |
NSC 328784 | 1-Piperazinecarboselenoic acid, 4-(2-pyridinyl)-, [1-(2-pyridinyl)ethylidene]hydrazide | 0.0378615809326463 | 0.14819821 |
NSC 339579 | 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate | 0.0378615809326463 | 0.47534154 |